To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
Status and phase
Conditions
Treatments
Details and patient eligibility
About
A research study to determine the efficacy of a 1320 nm laser device for the treatment of hidradenitis suppurativa.
Full description
Hidradenitis Suppurativa is a chronic, scarring disease. The treatments available for this condition are not very effective and work only for some patients.
Recently, a 1320nm laser device has been approved by the FDA for the treatment of acne and facial rejuvenation. Given the positive results seen with the use of this laser in the treatment of acne it is reasonable to hypothesize that a similar effect may be seen with the treatment of Hidradenitis suppurativa.
The specific aim of the study is to determine the efficacy of this device for the treatment of hidradenitis suppurativa as it relates to the patient's established treatment.
The investigators are trying to determine the efficacy of a laser for the treatment of hidradenitis suppurativa.
Patients will:
- be examined and interviewed
- have photographs taken of the treatment site
- have a 4mm punch biopsy performed
- have wound culture swabs performed
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age equal to or greater than 18 years
- General good health and willingness to participate and ability to comply with the study protocol
- Biopsy proven hidradenitis suppurativa
Exclusion criteria
- Age < 18 years
- Pregnancy
- Hx of collagen vascular or photosensitive disorders
- Inability to follow-up with treatments
Trial design
Primary purpose
Allocation
Interventional model
Masking
10 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal